BTK Inhibitors for Chronic Lymphocytic Leukemia: Rapid-Fire Highlights From the Past Year

Do you know what the latest chronic lymphocytic leukemia (CLL) clinical data are and what this could mean for your patients? Credit available for this activity expires: 8/10/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/993419?ecd=bdc_podcast_libsyn_mscpedu